Chloramphenicol-borate/boronate complex for controlling infections by chloramphenicol-resistant bacteria

Area of Science:

• Medicinal Chemistry
• Antimicrobial Resistance
• Drug Design

Background:

• Antibiotic resistance is a global health crisis, necessitating novel antimicrobial agents.
• Chloramphenicol efficacy is compromised by bacterial resistance, particularly through enzymatic inactivation.
• Understanding resistance mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To design, synthesize, and evaluate novel chloramphenicol-borate/boronate derivatives.
• To investigate the activity of these derivatives against chloramphenicol-resistant bacteria.
• To elucidate the mechanism of action and assess the safety profile of the new compounds.

Main Methods:

• Synthesis of chloramphenicol-borate/boronate derivatives.
• Antimicrobial activity profiling against resistant bacterial strains (e.g., P. aeruginosa EXR1).
• Molecular docking studies to analyze binding interactions with chloramphenicol acetyl transferase (CAT).
• Hemolytic and genotoxicity assays to evaluate safety.

Main Results:

• Chloramphenicol-borate/boronate derivatives demonstrated efficacy against chloramphenicol-resistant bacteria.
• Resistance mechanisms involving chloramphenicol acetyl transferase (CAT) were overcome.
• Molecular docking revealed altered binding interactions with CAT, explaining enhanced activity.
• Reduced hemolytic and genotoxic effects were observed compared to chloramphenicol.

Conclusions:

• Novel chloramphenicol-borate/boronate derivatives represent a promising strategy against antibiotic-resistant infections.
• The modified structure circumvents common resistance pathways mediated by CAT.
• These derivatives exhibit a favorable safety profile, warranting further investigation for clinical application.